methylprednisolone has been researched along with Graves Disease in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (13.39) | 18.7374 |
1990's | 25 (22.32) | 18.2507 |
2000's | 51 (45.54) | 29.6817 |
2010's | 12 (10.71) | 24.3611 |
2020's | 9 (8.04) | 2.80 |
Authors | Studies |
---|---|
Achok, HN; Chai, ST; Lim, YS | 1 |
Głogowska-Szeląg, J; Kajdaniuk, D; Kos-Kudła, B; Londzin-Olesik, M; Marek, B; Nowak, M; Nowak, W; Siemińska, L | 1 |
Miśkiewicz, P; Pelewicz-Sowa, M | 1 |
Belfiore, A; Frasca, F; Le Moli, R; Lo Giudice, F; Malandrino, P; Russo, M; Vigneri, R | 1 |
Karpe, J; Kos-Kudla, B; Londzin-Olesik, M; Nowak, A; Nowak, M | 1 |
Baumgarten, J; Bockisch, B; Gröner, D; Grünwald, F; Halstenberg, J; Happel, C; Kranert, WT; Sabet, A | 1 |
Liu, J; Lu, B; Shao, J; Wang, J; Ye, X; Zhao, H | 1 |
Hu, Y; Man, Y; Sun, X; Xue, Y | 1 |
Górska, M; Hryniewicka, J; Jankowska, D; Kościuszko, M; Krętowski, A; Lipińska, D; Myśliwiec, J; Pawłowski, P; Popławska-Kita, A | 1 |
Andrade, RJ; Contreras, F; Crespo, J; García-Cortés, M; González-Jiménez, A; Hernández, N; Lucena, MI; Medina-Cáliz, I; Ortega-Alonso, A; Pinazo-Bandera, J; Robles-Díaz, M; Sanabria-Cabrera, J; Sanjuan-Jiménez, R; Zoubek, ME | 1 |
Bruguera-Àvila, N; Garcia-Olivé, I; Martínez-Barenys, C; Pérez-Ochoa, JF; Ruiz-Manzano, J; Sánchez-Martínez, E | 1 |
Gupta, M; Mehta, VK; Verma, R | 1 |
Hasegawa, K; Moniwa, N; Ogawa, Y; Shimamura, Y; Takizawa, H; Tsushima, T | 1 |
Chang, JS; Chang, TC | 1 |
Kajdaniuk, D; Karpe, J; Kos-Kudła, B; Marek, B; Nowak, M; Siemińska, L | 1 |
Chiang, HC; Mull, JL; Musiek, A; Mutizwa, MM; Rosman, IS; Solus, JF | 1 |
Wiersinga, WM | 1 |
Hayashi, Y; Hozumi, I; Inuzuka, T; Kimura, A; Koumura, A; Sakurai, T; Tanaka, Y; Yoneda, M | 1 |
Colombo, M; Curtò, NA; DiFrancesco, JC; Ferrarese, C; Gelosa, G; Lanzani, F; Marzorati, L; Massimini, D; Perego, P; Rota, S; Tremolizzo, L | 1 |
Bałdys-Waligórska, A; Gołkowski, F; Hubalewska-Dydejczyk, A; Sokołowski, G; Stefańska, A | 1 |
Cheng, S; Vu, P | 1 |
Ando, J; Hirata, Y; Hourai, Y; Minami, R; Miyamura, T; Nakamura, M; Suematsu, E; Takahama, S; Torigoe, M; Yamamoto, M | 1 |
Khan, NA; Singh, M | 1 |
Beck-Peccoz, P; Bonara, P; Campi, I; Covelli, D; Currò, N; Dazzi, D; Guastella, C; Maffini, A; Pignataro, L; Ratiglia, R; Salvi, M; Vannucchi, G | 1 |
Boletis, J; Gakiopoulou, H; Georgalis, A; Lionaki, S; Petra, C; Vlachopanos, G; Ziakas, P | 1 |
Maruyama, T; Nakashima, K; Sano, A; Sarui, H; Takeda, N; Yasuda, K | 1 |
Arslan, M; Atasever, T; Ayvaz, G; Cakir, N; Hasanreisoglu, B; Konuk, O; Unal, M; Yetkin, I | 1 |
Kinalska, I; Kretowski, A; Mirończuk, K; Myśliwiec, J; Stepień, A | 2 |
Mehta, AB; Shaw, B | 1 |
Kinalska, I; Kretowski, A; Myśliwiec, J; Stepień, A; Topolska, J | 1 |
Hashimoto, M; Kawaguchi, S; Ohtsuka, K; Sato, A; Suzuki, Y | 1 |
Baraniak, A; Krzyzanowska-Swiniarska, B; Kulig, G; Kulig, J; Pilarska, K; Robaczyk, M | 1 |
Brovkina, AF | 1 |
Bellastella, A; Bizzarro, A; Conte, M; Coronella, C; De Bellis, A; Guaglione, M; Perrino, S; Sansone, D; Solimeno, S; Wall, JR | 1 |
Imamura, A; Kusuhara, T; Nakajima, M | 1 |
Chida, K; Enomoto, N; Fujisawa, T; Hashizume, H; Ide, K; Kuwata, H; Matsuda, H; Matsushita, A; Miwa, S; Nakamura, H; Nakano, H; Suda, T; Suzuki, K; Yokomura, K | 1 |
Bednarek, J; Gembicki, M; Modelska-Ziółkiewicz, A; Sowiński, J | 1 |
Brauer, VF; Scholz, GH | 1 |
Kinalska, I; Kretowski, A; Myśliwiec, J; Stepień, A | 1 |
Ai, S; Chen, Z; He, J; Mao, Y; Wu, Z; Yan, J; Yang, H | 1 |
Beck-Peccoz, P; Carnevali, A; Del Castello, AB; Fargion, S; Salvi, M; Sbrozzi, F; Vannucchi, G | 1 |
Badelon, I; Morax, S | 1 |
Chen, T; Huang, X; Liang, Y; Lin, Z; Liu, G; Wu, H; Wu, Z; Yang, H | 1 |
Kinalska, I; Kretowski, A; Myśliwiec, J; Okłota, M; Stepień, A | 1 |
Kaźmierczyk-Puchalska, A; Krzyzanowska-Swiniarska, B; Kulig, G; Pilarska, K | 2 |
Aaron, L; Alyanakian, MA; Desbene, C; Fakhouri, F; Karras, A; Lesavre, P; Noël, LH; Thaunat, O | 1 |
Genovesi, M; Grasso, L; Linda Morselli, L; Lupi, I; Manetti, L; Martino, E; Pardini, E; Pellegrini, G | 1 |
Altea, MA; Ambrogini, E; Bartalena, L; Brunetto, MR; Campani, D; Marcocci, C; Marinò, M; Morabito, E; Oliveri, F; Pincheral, A; Pollina, LE; Vitti, P | 1 |
Dittmar, M; Hommel, G; Kahaly, GJ; Pitz, S | 1 |
Crombie, A; Hart, RH; Kendall-Taylor, P; Perros, P | 1 |
Baldeschi, L; Mourits, MP; Prummel, MF; Saeed, P; Wakelkamp, IM; Wiersinga, WM | 1 |
Amino, N; Fukata, S; Ito, M; Kubota, S; Kudo, T; Kuma, K; Miyauchi, A; Nishihara, E; Ohye, H | 1 |
Kida, M; Kuroda, H; Matsumoto, M; Matsunaga, T; Niitsu, Y; Watanabe, H | 1 |
Avignone, S; Beck-Peccoz, P; Bonara, P; Campi, I; Guastella, C; Pirola, G; Ratiglia, R; Rossi, S; Salvi, M; Sbrozzi, F; Vannucchi, G | 1 |
Beck-Peccoz, P; Bonara, P; Campi, I; Currò, N; Dazzi, D; Guastella, C; Ratiglia, R; Rossi, S; Salvi, M; Simonetta, S; Sina, C; Vannucchi, G | 1 |
Chae, HJ; Han, K; Oh, EJ; Park, JW; Park, YJ | 1 |
Buranasupkajorn, P; Snabboon, T; Sridama, V; Wongraoprasert, S | 1 |
Cai, JP; Cheng, JW; Wei, RL | 1 |
Bijlsma, WR; Kalmann, R; Koppeschaar, HP; Mourits, MP; Sasim, IV; Stravers, SN; van Geest, RJ | 1 |
Antova, M; Bogoev, M; Laban-Guceva, N | 1 |
Andreani, D; Bartalena, L; Baschieri, L; Cavallacci, G; Chiovato, L; Laddaga, M; Lepri, G; Marcocci, C; Pinchera, A | 1 |
Cordonnier, M; Van Nechel, C; Vanheesbeke, A; Waterschoot, MP; Zanen, A | 1 |
Futami, S; Hoshi, H; Jinnouchi, S; Morita, M; Murakami, N; Nagamachi, S; Nakahara, H; Noguchi, S; Ohnishi, T; Tamaru, M | 1 |
Goto, Y; Kohda, H; Mizuta, T; Ohtsuka, Y; Ozaki, I; Sakai, T; Setoguchi, Y; Yamamoto, K | 1 |
Horimoto, M; Inada, M; Mori, S; Nishikawa, M; Ogawa, Y; Yoshikawa, N; Yoshimura, M | 1 |
Fujiwara, K; Hayakawa, K; Koh, T; Koshiyama, H; Misaki, T; Shimbo, S | 1 |
Hiromatsu, Y; Kaise, N; Kojima, K; Kuroki, T; Nishida, H; Nishimura, H; Nonaka, K; Sato, M; Tanaka, K | 1 |
Futami, S; Harao, M; Hoshi, H; Jinnouchi, S; Kawamoto, H; Murakami, N; Nagamachi, S; Noguchi, S; Ohnishi, T; Tajiri, J | 1 |
Fujiwara, K; Hayakawa, K; Koh, T; Koshiyama, H; Mori, S | 1 |
Hauff, W; Till, P; Weissel, M; Zielinski, CC | 1 |
Greten, T; Mündlein, E; Ritz, E | 1 |
Furuya, H; Kato, Y; Murakami, Y; Sohmiya, M; Wakayama, T | 1 |
Andris, C; Duchesne, B; Joachim, M | 1 |
Chang, TC; Hsiao, YL; Huang, KM; Kao, SC; Lu, CP; Tzeng, SS | 1 |
Chang, TC; Hsiao, YL; Huang, KM; Kao, SC; Tzeng, SS | 1 |
Brun, JM; Brun-Pacaud, A; Matejka, G; Petit, JM; Rudoni, S; Vaillant, G; Vergès, B | 1 |
Prummel, MF; Wiersinga, WM | 1 |
Bonavolonta, G; Colao, A; Fenzi, G; Ferone, D; Lastoria, S; Lombardi, G; Macchia, PE; Muto, P; Pivonello, R; Vassallo, P | 1 |
Heufelder, AE; Schworm, HD | 1 |
Chatterjee, VK; Coles, AJ; Compston, A; Coraddu, F; Greer, S; Hale, G; Smith, S; Taylor, C; Waldmann, H; Weetman, A; Wing, M | 1 |
Entremont, A; Hautecouverture, M; Huet, D | 1 |
Barbesino, G; Bartalena, L; Dell'Unto, E; Manetti, L; Marcocci, C; Mazzi, B; Pinchera, A; Rocchi, R; Tanda, ML | 1 |
Chen, MD; Kao, CH; Lee, WJ; Sheu, WH; Song, YM | 1 |
Abe, M; Fukada, S; Hagiwara, M; Hirota, S; Hishikawa, Y; Kono, M; Takada, Y; Tsujino, K | 1 |
Akamizu, T; Kaneko, H; Kashii, S; Nakao, K; Noguchi, N | 1 |
Bagattini, M; Fenzi, G; Lupoli, G; Macchia, PE; Vitale, G; Vitale, M | 1 |
Barbesino, G; Bartalena, L; Bartolomei, MP; Cartei, F; Dell'Unto, E; Lepri, P; Manetti, L; Marcocci, C; Mazzi, B; Nardi, M; Pinchera, A; Rocchi, R; Tanda, ML | 1 |
Krzystolik, Z; Kulig, G; Pilarska, K | 1 |
Jakubczyk, D; Kinalska, I; Kretowski, A; Mikita, A; Myśliwiec, J; Siewko, K; Szelachowska, M; Topolska, J | 1 |
Heufelder, A; Karma, A; Kauppinen-Mäkelin, R; Leinonen, E; Löyttyniemi, E; Salonen, O; Sane, T; Setälä, K; Välimäki, M; Viikari, J | 1 |
Mroczek-Madziarowa, D | 1 |
Hiromatsu, Y; Hoshino, T; Kojima, K; Kurose, S; Nakashima, A; Nonaka, K; Sato, K; Sato, M; Tanaka, K | 1 |
Hiromatsu, Y; Ishisaka, N; Kojima, K; Nishida, H; Nishimura, H; Nonaka, K; Sato, M; Tanaka, K | 1 |
Egan, JG; Keston Jones, M; Morris, GC | 1 |
Alberti, B; Antonelli, A; Baschieri, L; Cartei, F; Laddaga, M; Lepri, A; Melosi, A; Saracino, A | 1 |
Hiromatsu, Y; Kojima, K; Nishida, H; Nishimura, H; Nonaka, K; Sato, M; Tanaka, K | 1 |
Izumi, M; Nagataki, S | 1 |
Dandona, P; Havard, CW; Mier, A | 1 |
Höfer, R; Müller, C; Till, P; Weissel, M; Zielinski, CC | 1 |
Donovan, JP; Fagien, S; Guy, JR; Rubin, ML | 1 |
Crombie, AL; Hall, K; Hardwick, M; Kendall-Taylor, P; Stephenson, AM | 1 |
Bartalena, L; Baschieri, L; Campobasso, G; Cartei, F; Cavallacci, G; Laddaga, M; Marcocci, C; Marconcini, C; Panicucci, M; Pinchera, A | 1 |
Izumi, M; Kakezono, F; Kiriyama, T; Morimoto, I; Morita, S; Nagataki, S; Nagayama, Y; Ohtakara, S; Okamoto, S; Yokoyama, N | 1 |
Bixenman, WW; Buchsbaum, HW | 1 |
Bartalena, L; Cartei, F; Cavallacci, G; Laddaga, M; Lepri, A; Marcocci, C; Marconcini, C; Panicucci, M; Pinchera, A | 1 |
Glinoer, D; Schrooyen, M | 1 |
Garber, MI | 1 |
Aoki, N; Nagata, I; Wakisaka, G | 1 |
Carroll, FD; Day, RM | 1 |
Roelsen, E; Skjoerboek-Olesen, O | 1 |
12 review(s) available for methylprednisolone and Graves Disease
Article | Year |
---|---|
Dysthyroid optic neuropathy: emerging treatment strategies.
Topics: Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Methylprednisolone; Optic Nerve Diseases; Retrospective Studies | 2023 |
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.
Topics: Administration, Intravenous; Adult; Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Graves Disease; Humans; Liver Function Tests; Methylprednisolone; Middle Aged; Multiple Sclerosis | 2019 |
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
Topics: Animals; Antibodies, Monoclonal; Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Immunologic Factors; Methylprednisolone; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Treatment Outcome | 2017 |
[Simultaneous relapse of Basedow's disease in a patient with adult-onset Still's disease].
Topics: Female; Graves Disease; Humans; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Recurrence; Still's Disease, Adult-Onset; Treatment Outcome | 2011 |
Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease.
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Female; Graves Disease; HTLV-I Infections; Humans; Magnetic Resonance Imaging; Methimazole; Methylprednisolone; Middle Aged; Prednisolone; Propylthiouracil; Severity of Illness Index; Thyroid Hormones; Time Factors; Treatment Outcome; Uveitis; Vasculitis | 2002 |
[Recent aspects of pathogenesis and treatment of endocrine ophthalmopathy].
Topics: Anti-Inflammatory Agents; CD4 Antigens; Graves Disease; Humans; Injections, Intravenous; Methylprednisolone | 2003 |
[Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
Topics: Administration, Oral; Anti-Inflammatory Agents; Female; Glucocorticoids; Graves Disease; Humans; Immunoglobulins, Intravenous; Injections, Intravenous; Male; Meta-Analysis as Topic; Methylprednisolone; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors | 2004 |
[Medical treatment of dysthyroid orbitopathy].
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Eyeglasses; Graves Disease; Humans; Methylprednisolone; Ophthalmic Solutions; Prednisone; Smoking Cessation | 2004 |
The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
Topics: Administration, Oral; Adrenal Cortex Hormones; Cohort Studies; Combined Modality Therapy; Graves Disease; Humans; Infusions, Intravenous; Methylprednisolone; Orbit; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Localized myxedema, associated with increased serum hyaluronic acid, and response to steroid pulse therapy.
Topics: Administration, Oral; Aged; Drug Therapy, Combination; Graves Disease; Humans; Hyaluronic Acid; Injections, Intravenous; Male; Methylprednisolone; Myxedema; Prednisolone | 1995 |
Immunomodulatory treatment of Graves' ophthalmopathy.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Cyclosporine; Graves Disease; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Plasmapheresis; Prednisone | 1998 |
[Exophthalmos--what now?].
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Diagnosis, Differential; Exophthalmos; Graves Disease; Humans; Hyperthyroidism; Methylprednisolone; Nicotine; Ophthalmologic Surgical Procedures; Smoking Cessation | 1999 |
20 trial(s) available for methylprednisolone and Graves Disease
Article | Year |
---|---|
Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.
Topics: Administration, Intravenous; Adult; Antithyroid Agents; Diplopia; Exophthalmos; Eye Pain; Female; Glucocorticoids; Glycosides; Graves Disease; Graves Ophthalmopathy; Humans; Hypothyroidism; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Plant Extracts; Severity of Illness Index; Single-Blind Method; Thyroxine; Treatment Outcome; Tripterygium; Visual Acuity | 2021 |
[Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
Topics: Antibodies; Combined Modality Therapy; Disease Progression; Graves Disease; Humans; Iodine Radioisotopes; Methylprednisolone; Middle Aged; Orbital Diseases; Thyrotropin; Thyroxine | 2009 |
Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Topics: Adult; Female; Glucocorticoids; Graves Disease; Humans; Hypertrophy; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Orbit; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[Usefulness of soluble ICAM-1 measurements for the evaluation of the disease activity and efficiency of therapy in patients with infiltrative Graves' ophthalmopathy].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Female; Graves Disease; Humans; Intercellular Adhesion Molecule-1; Male; Methylprednisolone; Middle Aged; Severity of Illness Index; Statistics, Nonparametric | 2002 |
High-dose intravenous glucocorticoid therapy abrogates circulating dendritic cells.
Topics: Dendritic Cells; Female; Glucocorticoids; Graves Disease; Humans; Infusions, Intravenous; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged | 2003 |
Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy.
Topics: Administration, Oral; Adult; Aged; Aging; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Graves Disease; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Patient Satisfaction; Prednisolone; Quality of Life; Severity of Illness Index; Sex Factors; Single-Blind Method; Smoking | 2005 |
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
Topics: Acute Disease; Adult; Decompression, Surgical; Female; Follow-Up Studies; Glucocorticoids; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Optic Neuropathy, Ischemic; Prednisolone; Pulse Therapy, Drug; Treatment Outcome; Visual Acuity | 2005 |
Effect of high dose methylprednisolone pulse therapy followed by oral prednisolone administration on the production of anti-TSH receptor antibodies and clinical outcome in Graves' disease.
Topics: Administration, Oral; Adult; Autoantibodies; Case-Control Studies; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulin E; Immunoglobulins, Thyroid-Stimulating; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Receptors, Thyrotropin; Remission Induction; Time Factors; Treatment Outcome | 2005 |
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; B-Lymphocytes; Female; Graves Disease; Graves Ophthalmopathy; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Rituximab; Thyroid Function Tests; Thyroid Hormones | 2007 |
Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study.
Topics: Adult; Aged; Double-Blind Method; Female; Glucocorticoids; Graves Disease; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prospective Studies; Pulse Therapy, Drug; Severity of Illness Index; Treatment Outcome | 2008 |
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Clinical Trials as Topic; Cobalt Radioisotopes; Eye; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Optic Nerve; Orbit; Random Allocation | 1983 |
Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
Topics: Adult; Aged; Combined Modality Therapy; Diplopia; Female; Graves Disease; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged | 1994 |
Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
Topics: Adult; Aged; CD4 Lymphocyte Count; Enzyme-Linked Immunosorbent Assay; Eye Diseases; Female; Flow Cytometry; Graves Disease; Humans; Injections, Intravenous; Intraocular Pressure; Killer Cells, Natural; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; T-Lymphocytes; Visual Acuity | 1993 |
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Topics: Adult; Female; Glucocorticoids; Graves Disease; Humans; Indium Radioisotopes; Male; Methylprednisolone; Middle Aged; Octreotide; Orbit; Pentetic Acid; Prognosis; Radionuclide Imaging; Treatment Outcome | 1998 |
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antirheumatic Agents; B-Lymphocyte Subsets; CD4 Antigens; CD52 Antigen; Drug Administration Schedule; Female; Follow-Up Studies; Glycoproteins; Graves Disease; Humans; Lymphocyte Activation; Male; Methylprednisolone; Multiple Sclerosis, Chronic Progressive; Pulse Therapy, Drug; Receptors, Tumor Necrosis Factor; T-Lymphocyte Subsets; Th1 Cells; Thyroiditis, Autoimmune | 1999 |
High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
Topics: Abdominal Pain; Adult; Erythema; Exophthalmos; Female; Glucocorticoids; Graves Disease; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisone; Treatment Outcome | 2001 |
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Topics: Administration, Oral; Bone Density; Combined Modality Therapy; Diplopia; Exophthalmos; Eyelids; Female; Glucocorticoids; Graves Disease; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Optic Nerve; Prospective Studies; Single-Blind Method; Smoking; Thyrotropin; Thyroxine; Triiodothyronine | 2001 |
High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Diplopia; Exophthalmos; Female; Glucocorticoids; Graves Disease; Humans; Infusions, Intravenous; Intraocular Pressure; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Prednisolone; Pulse Therapy, Drug; Treatment Outcome; Visual Acuity | 2002 |
Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study.
Topics: Adult; Aged; Clinical Trials as Topic; Cobalt Radioisotopes; Combined Modality Therapy; Eye; Female; Graves Disease; Humans; Injections; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Random Allocation | 1987 |
Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Graves Disease; Humans; Infusions, Intravenous; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Oculomotor Muscles; Orbit; Tomography, X-Ray Computed; Vision Tests | 1987 |
80 other study(ies) available for methylprednisolone and Graves Disease
Article | Year |
---|---|
When polymyositis meets Graves' disease: A rare case report.
Topics: Adult; Female; Graves Disease; Humans; Methylprednisolone; Muscular Diseases; Myositis; Polymyositis; Young Adult | 2021 |
[Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z
Topics: Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Methylprednisolone; Rituximab | 2022 |
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism.
Topics: Adrenal Cortex Hormones; Adult; Antithyroid Agents; Female; Graves Disease; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome | 2020 |
The Effect of Immunosuppression on Selected Antioxidant Parameters in Patients with Graves' Disease with Active Thyroid-Associated Orbitopathy.
Topics: Adult; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Lipid Peroxidation; Male; Methylprednisolone; Middle Aged; Oxidative Stress | 2021 |
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of
Topics: Graves Disease; Half-Life; Humans; Iodine Radioisotopes; Methylprednisolone; Retrospective Studies | 2021 |
Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves' disease.
Topics: Administration, Oral; Adolescent; Antithyroid Agents; Autoantibodies; Case-Control Studies; Child; Child, Preschool; Female; Glucocorticoids; Graves Disease; Humans; Male; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Retrospective Studies; Thyroid Hormones | 2021 |
Clinical relevance of estimating circulating interleukin-17 and interleukin-23 during methylprednisolone therapy in Graves' orbitopathy: A preliminary study.
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Interleukin-17; Interleukin-23; Methylprednisolone | 2021 |
Obliterating bronchiolitis in a patient treated with (D)-penicillamine.
Topics: Bronchiolitis Obliterans; Bronchodilator Agents; Chelating Agents; Chelation Therapy; Combined Modality Therapy; Copper; Dyslipidemias; Graves Disease; Hepatolenticular Degeneration; Humans; Hypertension; Lung Transplantation; Male; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Penicillamine; Respiratory Insufficiency; Tomography, X-Ray Computed | 2013 |
Thyroid associated orbitopathy.
Topics: Adult; Female; Graves Disease; Humans; Methylprednisolone; Orbital Diseases; Treatment Outcome; Visual Acuity | 2013 |
Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves' disease: a case report.
Topics: Antithyroid Agents; Biopsy; Female; Glomerulonephritis, IGA; Glucocorticoids; Graves Disease; Humans; Kidney; Methylprednisolone; Middle Aged; Nephritis, Interstitial; Prednisolone; Propylthiouracil; Syndrome; Treatment Outcome; Uveitis | 2014 |
Hashimoto's encephalopathy: report of three cases.
Topics: Aged; Autoantibodies; Brain Diseases; Encephalitis; Female; Graves Disease; Hallucinations; Hashimoto Disease; Humans; Hypothyroidism; Male; Methylprednisolone; Middle Aged; Thyroid Gland; Thyroiditis, Autoimmune; Thyrotoxicosis | 2014 |
Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
Topics: Adult; Case-Control Studies; Female; Graves Disease; Graves Ophthalmopathy; Hepatocyte Growth Factor; Humans; Interleukin-8; Male; Methylprednisolone; Middle Aged | 2016 |
Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical and histopathologic findings.
Topics: Adult; Anorexia; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antithyroid Agents; Blister; Eyelid Diseases; Fatigue; Female; Graves Disease; Hemorrhage; Humans; Immunosuppressive Agents; Methylprednisolone; Pancytopenia; Pharyngitis; Prednisone; Propylthiouracil; Respiratory Insufficiency | 2015 |
[Case report of a patient with Hashimoto's encephalopathy associated with Basedow's disease mimicking Creutzfeldt-Jakob disease].
Topics: Aged; Autoantibodies; Biomarkers; Biomarkers, Tumor; Brain Diseases; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; DNA-Binding Proteins; Electroencephalography; Female; Graves Disease; Hashimoto Disease; Humans; Magnetic Resonance Imaging; Methylprednisolone; Phosphopyruvate Hydratase; Pulse Therapy, Drug; Tomography, Emission-Computed, Single-Photon; Tumor Suppressor Proteins | 2008 |
Autoimmune encephalopathy in Graves' disease: remission after total thyroidectomy.
Topics: Allergy and Immunology; Autoimmune Diseases of the Nervous System; Diagnosis, Differential; Electroencephalography; Graves Disease; Humans; Infusions, Intravenous; Iodide Peroxidase; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neurologic Examination; Receptors, Thyrotropin; Recurrence; Thyroidectomy; Thyroiditis, Autoimmune | 2009 |
Recurrent orbital myositis with radiological feature mimicking thyroid eye disease in a patient with Crohn's disease.
Topics: Adult; Crohn Disease; Diagnosis, Differential; Female; Glucocorticoids; Graves Disease; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Mercaptopurine; Methylprednisolone; Oculomotor Muscles; Orbital Myositis; Recurrence; Scleritis; Tomography, X-Ray Computed; Uveitis, Anterior | 2009 |
Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease independent of anti-thyroid drug therapy.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Azathioprine; Biomarkers; Drug Therapy, Combination; Glucocorticoids; Graves Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myeloblastin; Propylthiouracil; Remission Induction; Skin; Testis; Treatment Outcome | 2012 |
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; B-Cell Activating Factor; B-Lymphocytes; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Rituximab; Treatment Outcome | 2012 |
Lupus nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antithyroid Agents; Biopsy, Needle; Bone Marrow Examination; Cyclophosphamide; Drug Therapy, Combination; Graves Disease; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphoma, B-Cell; Male; Methimazole; Methylprednisolone; Renal Dialysis; Risk Factors; Rituximab; Treatment Outcome | 2013 |
Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
Topics: Adult; Aged; Citrates; Control Groups; Female; Gallium; Gallium Radioisotopes; Gamma Cameras; Graves Disease; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Orbit; ROC Curve; Tomography, Emission-Computed, Single-Photon | 2002 |
Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy?
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Case-Control Studies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Methylprednisolone; Middle Aged; Prednisone; Receptors, Thyrotropin; Recombinant Proteins | 2002 |
Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carbimazole; Cyclophosphamide; Doxorubicin; Graves Disease; Gynecomastia; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Ribs; Spinal Neoplasms; Thoracic Vertebrae; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2002 |
[The influence of corticosteroids on IL-6/IL-6R system in patients with Graves' ophthalmopathy].
Topics: Adult; Aged; Anti-Inflammatory Agents; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; Immunosuppression Therapy; Interleukin-6; Male; Methylprednisolone; Middle Aged; Prednisone; Receptors, Interleukin-6; Time Factors | 2002 |
Interleukin 18 and transforming growth factor beta1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids.
Topics: Adrenal Cortex Hormones; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Immunosuppressive Agents; Interleukin-18; Male; Methylprednisolone; Middle Aged; Prednisone; Transforming Growth Factor beta | 2003 |
Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
Topics: Adult; Antithyroid Agents; Autoantibodies; Biomarkers; Diplopia; Exophthalmos; Eye; Eye Proteins; Female; Follow-Up Studies; Glucocorticoids; Graves Disease; Humans; Infusions, Intravenous; Male; Membrane Proteins; Methimazole; Methylprednisolone; Middle Aged; Receptors, Thyrotropin; Statistics, Nonparametric | 2003 |
Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
Topics: Aged; Anti-Inflammatory Agents; Eye Diseases; Female; Graves Disease; Humans; Immunization, Passive; Magnetic Resonance Imaging; Methylprednisolone; Myasthenia Gravis; Vision Disorders | 2003 |
[Prognostic role of adhesion molecules sELAM-1 and sICAM-1 in glucocorticoid therapy of active ophthalmopathy].
Topics: Anti-Inflammatory Agents; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Female; Graves Disease; Humans; Intercellular Adhesion Molecule-1; Male; Methylprednisolone; Middle Aged; Prednisone; Prospective Studies | 2003 |
Serum levels of soluble TNFalpha receptors (sTNFR1 and sTNFR2) during corticosteroid treatment in patients with Graves' ophthalmopathy.
Topics: Adult; Anti-Inflammatory Agents; Case-Control Studies; Female; Graves Disease; Humans; Immunosuppression Therapy; Male; Methylprednisolone; Middle Aged; Prednisone; Receptors, Tumor Necrosis Factor | 2004 |
Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy.
Topics: Adult; Aged; China; Diagnosis, Differential; Female; Glaucoma; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Ocular Hypertension | 2004 |
Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report.
Topics: Acute Disease; Adult; Female; Glucocorticoids; Graves Disease; Hepatitis, Autoimmune; Humans; Injections, Intravenous; Methylprednisolone; Pulse Therapy, Drug; Thyroiditis, Autoimmune | 2004 |
Study on IL-1alpha, IL-1beta and sIL-1ra in sera of patients with Graves' ophthalmopathy.
Topics: Adult; Biomarkers; Female; Glucocorticoids; Graves Disease; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Male; Methylprednisolone; Middle Aged; Sialoglycoproteins; Smoking | 2002 |
[Serum Fas in patients with Graves' ophthalmopathy as a marker of activity of the ocular inflammatory infiltration].
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; fas Receptor; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Predictive Value of Tests; Prednisolone; Radioimmunoassay; Thyrotropin | 2004 |
[Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University].
Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Radiation Dosage; Retrospective Studies; Treatment Outcome | 2004 |
[Complications during systemic corticosteroid therapy combined with orbital radiotherapy in patients with graves orbitopathy].
Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Radiation Dosage; Treatment Outcome | 2004 |
Type III cryoglobulinemia complicated by renal cortical necrosis.
Topics: Arthritis, Rheumatoid; Biopsy; Combined Modality Therapy; Cryoglobulinemia; Cyclophosphamide; Drug Therapy, Combination; Female; Graves Disease; Humans; Immunosuppressive Agents; Kidney Cortex Necrosis; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Plasmapheresis; Prednisone; Urticaria | 2005 |
Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves' ophthalmopathy.
Topics: Creatinine; Cystatin C; Cystatins; Female; Graves Disease; Humans; Male; Methylprednisolone | 2005 |
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves.
Topics: Adult; Anti-Inflammatory Agents; Body Mass Index; Female; Glucocorticoids; Graves Disease; Hepatitis, Autoimmune; Humans; Liver; Liver Function Tests; Lymphocytes; Methylprednisolone; Prednisone | 2005 |
Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome.
Topics: Adult; Aged; Anti-Inflammatory Agents; Diplopia; Dose-Response Relationship, Drug; Drug Administration Schedule; Exophthalmos; Female; Follow-Up Studies; Graves Disease; Humans; Injections, Intravenous; Intraocular Pressure; Male; Methylprednisolone; Middle Aged; Prospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Visual Acuity | 2005 |
[Basedow disease associated with Evans syndrome].
Topics: Anemia, Hemolytic, Autoimmune; Drug Therapy, Combination; Female; Graves Disease; Humans; Methimazole; Methylprednisolone; Middle Aged; Plasma Exchange; Pulse Therapy, Drug; Purpura, Thrombocytopenic, Idiopathic; Syndrome; Treatment Outcome | 2005 |
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Lymphocytes; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; Immunohistochemistry; Immunologic Factors; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Subsets; Methylprednisolone; Middle Aged; Orbit; Receptors, Thyrotropin; Rituximab; T-Lymphocytes; Thyroidectomy; Thyrotropin; Thyroxine | 2006 |
Agranulocytosis, plasmacytosis, and thrombocytosis due to methimazole-induced bone marrow toxicity.
Topics: Adult; Agranulocytosis; Bone Marrow; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Graves Disease; Humans; Male; Methimazole; Methylprednisolone; Plasma Cells; Thrombocytosis; Treatment Outcome | 2007 |
Thyrotoxic periodic paralysis induced by pulse methylprednisolone.
Topics: Adult; Glucocorticoids; Graves Disease; Humans; Hypokalemic Periodic Paralysis; Male; Methylprednisolone; Polyneuropathies; Pulse Therapy, Drug; Thyrotoxicosis | 2007 |
Serum concentrations of interleukin (IL-)1alpha, 1beta, 6 and tumor necrosis factor (TNF-) alpha in patients with thyroid eye disease (TED).
Topics: Female; Graves Disease; Humans; Interleukin-1; Interleukin-6; Male; Methylprednisolone; Middle Aged; Tumor Necrosis Factor-alpha | 2007 |
[Is treatment with corticotherapy or radiotherapy effective for involvement of ocular motility and for reduction of exophthalmos in Basedow's disease?].
Topics: Adult; Aged; Exophthalmos; Eye Movements; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Treatment Failure | 1994 |
Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
Topics: Conjunctival Diseases; Diplopia; Drug Combinations; Edema; Eye Diseases; Female; Follow-Up Studies; Graves Disease; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Muscular Diseases; Oculomotor Muscles; Prednisolone; Radiotherapy Dosage; Recurrence; Remission Induction | 1995 |
Thyroid stimulating antibody in sera of Graves' ophthalmopathy patients as a possible marker for predicting the efficacy of methylprednisolone pulse therapy.
Topics: Adolescent; Adult; Aged; Autoantibodies; Autoantigens; Eye; Eye Diseases; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Methylprednisolone; Middle Aged; Thyrotropin | 1995 |
Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
Topics: Adipose Tissue; Adult; Female; Graves Disease; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Oculomotor Muscles; Orbit; Prednisolone; Radiotherapy, High-Energy | 1994 |
Successful treatment of hypothyroid Graves' disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit.
Topics: Combined Modality Therapy; Drug Therapy, Combination; Female; Graves Disease; Humans; Infusions, Intravenous; Methylprednisolone; Middle Aged; Myxedema; Orbit; Thyroxine | 1993 |
[Combined therapy with cyclosporin A and cortisone in endocrine Basedow endocrine orbitopathy: successful use in compressive optic neuropathy].
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Nerve Compression Syndromes; Optic Nerve Diseases; Visual Fields | 1993 |
Graves' disease and sarcoidosis in a patient with minimal-change glomerulonephritis.
Topics: Adult; Autoimmune Diseases; Cyclophosphamide; Graves Disease; Humans; Male; Methylprednisolone; Nephrosis, Lipoid; Sarcoidosis | 1996 |
Increased serum human granulocyte colony-stimulating factor (G-CSF) levels following intravenous infusion of high-dose methylprednisolone.
Topics: Adult; Aged; Female; Granulocyte Colony-Stimulating Factor; Graves Disease; Hematologic Diseases; Humans; Infusions, Intravenous; Kinetics; Male; Methylprednisolone; Middle Aged | 1996 |
[Pharma-clinics. How I treat ... thyroid ophthalmopathy].
Topics: Adult; Aged; Autoimmune Diseases; Combined Modality Therapy; Female; Graves Disease; Humans; Hyperthyroidism; Male; Methylprednisolone; Middle Aged; Orbit; Plasmapheresis; Radiotherapy | 1996 |
Therapeutic responses to corticosteroids in Graves' ophthalmopathy.
Topics: Adrenal Cortex Hormones; Adult; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Prednisolone; Prognosis; Visual Acuity | 1996 |
Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy.
Topics: Adult; Drug Administration Routes; Female; Follow-Up Studies; Glucocorticoids; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Orbit; Prednisolone; Prognosis; Recurrence; Severity of Illness Index; Tomography, X-Ray Computed | 1997 |
Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Ophthalmology; Outpatients; Smoking; Tomography; Treatment Outcome | 1998 |
[Basedow's disease and interferon for hepatitis C. Recurrence as Basedow's ophthalmopathy after interferon reintroduction].
Topics: Anti-Inflammatory Agents; Antithyroid Agents; Antiviral Agents; Autoimmunity; Carbimazole; Graves Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Methylprednisolone; Middle Aged; Recurrence; Time Factors | 2000 |
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Case-Control Studies; Female; Glucocorticoids; Graves Disease; Humans; Interleukin 1 Receptor Antagonist Protein; Linear Models; Male; Methimazole; Methylprednisolone; Middle Aged; Sialoglycoproteins; Smoking; Statistics, Nonparametric; Thyroxine; Treatment Outcome | 2000 |
Methylprednisolone increases plasma leptin levels in Graves' hyperthyroidism patients with active Graves' ophthalmopathy.
Topics: Adult; Aged; Blood Glucose; Eye Diseases; Fatty Acids, Nonesterified; Female; Graves Disease; Humans; Injections, Intravenous; Insulin; Kinetics; Leptin; Lipids; Male; Methylprednisolone; Middle Aged; Prednisolone; Tumor Necrosis Factor-alpha | 2000 |
Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Glucocorticoids; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Prednisolone; Radiotherapy; Recurrence; Retrospective Studies; Treatment Outcome | 2000 |
Moisture chamber for management of corneal ulcer due to Graves' ophthalmopathy.
Topics: Corneal Ulcer; Female; Graves Disease; Humans; Humidity; Methylprednisolone; Middle Aged; Ofloxacin; Polyethylene; Pulse Therapy, Drug | 2000 |
[The assessment of urinary glycosaminoglycans (GAG) excretion during therapy of patients with progressive Graves' ophthalmopathy].
Topics: Adult; Anti-Inflammatory Agents; Female; Glycosaminoglycans; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged | 2001 |
Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; Interferon-gamma; Interleukin-10; Interleukin-4; Male; Methylprednisolone; Middle Aged; Prednisone; Th1 Cells; Th2 Cells; Tumor Necrosis Factor-alpha | 2001 |
[Retrobulbar depo-medrol in treatment of thyroid-derived exophthalmos (author's transl)].
Topics: Adult; Aged; Delayed-Action Preparations; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged | 1979 |
Anti-eye muscle antibodies and hypothyroid Graves' disease: a case report.
Topics: Aged; Autoantibodies; Blotting, Western; Eye Diseases; Graves Disease; Humans; Hypothyroidism; Immunoglobulins, Thyroid-Stimulating; Lithium; Magnetic Resonance Imaging; Male; Methylprednisolone; Oculomotor Muscles; Thyroglobulin; Thyroid Gland; Thyroid Hormones; Thyroxine; Tomography, X-Ray Computed | 1992 |
Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy.
Topics: Adolescent; Adult; Aged; Child; Exophthalmos; Eye; Eye Diseases; Female; Graves Disease; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged | 1992 |
Hypokalaemic paralysis induced by bolus prednisolone in Graves' disease.
Topics: Adult; Graves Disease; Humans; Hypokalemia; Male; Methylprednisolone; Paralysis | 1992 |
[The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
Topics: Adult; Combined Modality Therapy; Female; Graves Disease; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Middle Aged; Orbit; Particle Accelerators; Radiotherapy Dosage; Remission Induction | 1992 |
[Prediction for effectiveness of steroid pulse therapy by MRI in Graves' ophthalmopathy].
Topics: Adipose Tissue; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Eye; Female; Follow-Up Studies; Graves Disease; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Predictive Value of Tests; Prognosis | 1992 |
[New therapeutic manual of malignant exophthalmos].
Topics: Administration, Oral; Combined Modality Therapy; Graves Disease; Humans; Injections, Intravenous; Methylprednisolone; Plasmapheresis; Prednisolone | 1991 |
Methylprednisolone and Graves' ophthalmopathy.
Topics: Exophthalmos; Graves Disease; Humans; Methylprednisolone | 1989 |
Long-term follow-up of patients with Graves' orbitopathy treated by plasmapheresis and immunosuppression.
Topics: Azathioprine; Combined Modality Therapy; Follow-Up Studies; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; Immunosuppression Therapy; Methylprednisolone; Microsomes; Middle Aged; Plasmapheresis; Prognosis; Thyroglobulin; Vision Tests | 1989 |
Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy.
Topics: Adult; Female; Graves Disease; Humans; Hydrochlorothiazide; Hypertension; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Orbit; Tomography, X-Ray Computed; Visual Acuity; Visual Fields | 1989 |
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; Injections, Intravenous; Intraocular Pressure; Male; Methylprednisolone; Middle Aged; Thyroid Gland; Visual Acuity | 1988 |
Multiple sclerosis, euthyroid restrictive Grave's ophthalmopathy, and myasthenia gravis. A case report.
Topics: Blepharoptosis; Diplopia; Graves Disease; Humans; Injections; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Multiple Sclerosis; Myasthenia Gravis; Oculomotor Muscles; Prednisone | 1988 |
Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
Topics: Combined Modality Therapy; Eye Diseases; Graves Disease; Humans; Injections; Methylprednisolone; Orbit; Radiation Dosage | 1987 |
Plasma exchange therapy for severe Graves' ophthalmopathy.
Topics: Combined Modality Therapy; Eye Diseases; Graves Disease; Humans; Methylprednisolone; Plasma Exchange; Plasmapheresis | 1987 |
Methylprednisolone in the treatment of exophthalmos.
Topics: Adult; Aged; Delayed-Action Preparations; Exophthalmos; Female; Glaucoma; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged | 1966 |
[Treatment of thyroid diseases with intrathyroidal injection of glucocorticoid].
Topics: Adult; Biopsy, Needle; Chronic Disease; Female; Glucocorticoids; Graves Disease; Humans; Injections; Male; Methylprednisolone; Middle Aged; Thyroid Diseases; Thyroid Gland; Thyroiditis; Thyroiditis, Autoimmune; Triamcinolone Acetonide | 1974 |
Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.
Topics: Adult; Aged; Exophthalmos; Eye Diseases; Female; Graves Disease; Humans; Male; Methylprednisolone; Middle Aged; Optic Nerve; Prednisone; Scotoma | 1968 |
[Malignant exophthalmos treated with methylprednisolone acetate].
Topics: Acetates; Female; Graves Disease; Humans; Methylprednisolone; Middle Aged | 1968 |